HLB Pharmaceutical Co., Ltd. (KOSDAQ: A047920)
Health Care · Pharmaceuticals · KR
₩13,130.00
+31.17% today · -2.8% 1Y
HLB Pharmaceutical Co., Ltd. (KOSDAQ: A047920) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $320.33M.
Over the last twelve months the share price has lost 2.8%, trading between 6.00K and 22.25K.
Tweenvest scores HLB Pharmaceutical Co., Ltd. across four factors: quality 63/100, value 68/100. Its strongest factor is value.
A047920 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $320.33M
- Revenue (TTM)
- $162.69M
- P/E
- 157.93
- EPS
- 83.14
- Dividend yield
- —
- Beta (5Y)
- 0.13
- 52-week high
- ₩22,250.00
- 52-week low
- ₩6,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 32.80M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ind-Swift Laboratories LimitedNSEI: INDSWFTLAB | $324.28M | Rs360.90 | -8.67% |
| Ouro Fino Saúde Animal Participações S.A.BOVESPA: OFSA3 | $323.80M | R$30.00 | +7.57% |
| Solara Active Pharma Sciences LimitedNSEI: SOLARA | $321.23M | Rs644.35 | -9.86% |
| Gulf Pharmaceutical Industries P.S.C.ADX: JULPHAR | $320.80M | AED1.02 | -0.97% |
| Standard Chemical & Pharmaceutical Co., Ltd.TWSE: 1720 | $317.99M | NT$56.90 | +1.43% |
| Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,LtdSZSE: 301130 | $316.94M | CN¥28.12 | -1.37% |
| Shukra Pharmaceuticals LimitedBSE: 524632 | $304.29M | Rs66.99 | +8.33% |
| Guiyang Xintian Pharmaceutical Co.,Ltd.SZSE: 002873 | $303.47M | CN¥8.55 | +2.03% |
Figures last refreshed Oct 11, 2026.